Study Shows Significant Increase In Medical Marketing Spending Over Past 2 Decades - WBUR

It's all too familiar — you're watching your favorite TV show, then it goes to a commercial break, and you see drug ads for everything from bipolar depression to severe rheumatoid arthritis.

A new study in the Journal of the American Medical Association finds that spending on medical marketing skyrocketed from $17.7 billion in 1997 to $29.9 billion in 2016, and that spending on advertising directly to patients rose the fastest.

Guest

Dr. Steven Woloshin, physician, professor and researcher at the Dartmouth Institute for Health Policy and Clinical Practice.

This segment aired on January 3, 2019.



https://wbur.fm/2TL37fl
-

Comments

Post a Comment

Popular Posts

What Happened to Jani and Bodhi Schofield? - Distractify

Image
Looking back at the craziest stories from the past few decades, some of us might remember the Schofield family. Susan Schofield first brought her daughter, Jani Schofield, into the limelight in a 2009 episode of The Oprah Winfrey Show , claiming that the then-7-year-old was diagnosed with schizophrenia. Article continues below advertisement Article continues below advertisement However, after Susan believed Jani's little brother, Bodhi, was also schizophrenic and began sharing intimate moments of his life with her YouTube followers, people started to get skeptical about what was actually true. It seemed more like Susan had Munchausen syndrome by proxy and that her husband at the time, Michael, enabled her. But in 2019, everything changed. So what happened to Jani and Bodhi Schofield? Article continues below advertisement Jani and Bodhi Schofield were removed from their parents' care in 2019. As Susan began sharing more and more videos of Jani and Bodhi, viewers had some cause f...
Read more

"mdd single episode moderate" - Google News

[unable to retrieve full-text content] Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study    Nature.com
Read more